Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2011
Oncolytic viruses in radiation oncologyYann Touchefeu, Georges Vassaux, Kevin J Harrington
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 20, 2013
Options for metastatic colorectal cancer beyond the second line of treatmentFanny Foubert, Tamara Matysiak-Budnik, Yann Touchefeu
Current Topics in Microbiology and Immunology|January 17, 2024
Clinical Management of Gastric Cancer Treatment RegimensJuliette Boilève, Yann Touchefeu, Tamara Matysiak-Budnik
Medecine Sciences : M/S|May 3, 2012
[Measles virus: a future therapeutic agent in oncology?]Yann Touchefeu, Ulrike Schick, Kevin J Harrington
Expert Opinion on Biological Therapy|January 19, 2020
Pembrolizumab for the treatment of colorectal cancerDahna Coupez, Pauline Hulo, Yann Touchefeu, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
Combining Immune Checkpoint Inhibitors with Loco-Regional Treatments in Hepatocellular Carcinoma: Ready for Prime Time?Juliette Boilève, Valentine Guimas, Arthur David, et al.
Expert Opinion on Biological Therapy|August 11, 2021
KRAS mutations in metastatic colorectal cancer: from a de facto ban on anti-EGFR treatment in the past to a potential biomarker for precision medicineDahna Coupez, Pauline Hulo, Yann Touchefeu, et al.
Bulletin Du Cancer|September 25, 2018
[Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment]Tilda Passat, Yann Touchefeu, Nadine Gervois, et al.
Case Reports in Oncology|January 13, 2023
Transthyretin Cardiac Amyloidosis Mimicking Immune Checkpoint-Induced Myocarditis in a Patient Treated with Atezolizumab and Bevacizumab for Advanced Hepatocellular Carcinoma: A Case ReportPierrine Le Bras, Louise Plard, Christèle Le Gouill, et al.
European Journal of Gastroenterology & Hepatology|September 23, 2025
Mild liver function decline in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma: a real-world studyVictoria Delhoume, Paul Girot, Marion Khaldi, et al.
Pageof 9